10-Q Filing

Astrana Health, Inc. CIK: 1083446 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001628280-22-021959`
Period End Date	20220630
Filing Date	20220809
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	ameh-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 111 Income Statement 76 Cash Flow Statement 131 Stockholders Equity 49

Balance Sheet 111 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$234.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$53.42M	USD	Point-in-time
Investments in marketable securities	`MarketableSecuritiesCurrent`	$39.49M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$10.61M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$67.26M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$69.38M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$81.53M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$12.64M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	-	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$13.23M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$9.65M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$18.64M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$12.67M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	44.63M	shares	Point-in-time
Loan receivable related party	`NotesAndLoansReceivableNetCurrent`	$4.00M	USD	Point-in-time
Loan receivable related party	`NotesAndLoansReceivableNetCurrent`	-	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	44.72M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	44.72M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	44.63M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$398.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$461.04M	USD	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	11.18M	shares	Point-in-time
Treasury shares (in shares)	`TreasuryStockCommonShares`	10.93M	shares	Point-in-time
Assets	`Assets`	$951.06M	USD	Point-in-time
Assets	`Assets`	$852.36M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$53.19M	USD	Point-in-time
Land, property, and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$87.15M	USD	Point-in-time
Liabilities	`Liabilities`	$425.22M	USD	Point-in-time
Liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$82.81M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$76.65M	USD	Point-in-time
Goodwill	`Goodwill`	$253.31M	USD	Point-in-time
Goodwill	`Goodwill`	$253.04M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$539.00K	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$569.00K	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	-	USD	Point-in-time
Loans receivable related parties	`NotesReceivableRelatedPartiesNoncurrent`	$2.12M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$43.82M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$41.72M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.44M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$19.64M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.90M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.93M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$490.03M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$453.58M	USD	Point-in-time
Total assets	`Assets`	$951.06M	USD	Point-in-time
Total assets	`Assets`	$852.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$43.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$59.92M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$10.53M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$6.07M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$59.31M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$50.33M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$55.78M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$112.50M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$652.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$556.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$556.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$524.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$486.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.25M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.63M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$780.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$2.41M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$115.37M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$185.24M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$9.13M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$9.26M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$973.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.05M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$16.90M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$13.20M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$199.07M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$182.92M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$14.78M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$13.71M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$239.98M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$220.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$425.22M	USD	Point-in-time
Total liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$40.00M	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,719,710 and 44,630,873 shares issued and outstanding, excluding 11,175,702 and 10,925,702 treasury shares, as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$45.00K	USD	Point-in-time
Common stock, $0.001 par value per share; 100,000,000 shares authorized, 44,719,710 and 44,630,873 shares issued and outstanding, excluding 11,175,702 and 10,925,702 treasury shares, as of June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$45.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$310.63M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$310.88M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$143.63M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$169.29M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$479.97M	USD	Point-in-time
Total stockholders' equity, parent	`StockholdersEquity`	$454.55M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$5.94M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$5.88M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$852.36M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$951.06M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$532.95M	USD	2 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$269.70M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$175.64M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$351.70M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$450.80M	USD	2 Qtrs
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$230.07M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$136.21M	USD	1 Quarter
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$276.83M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$19.89M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$23.66M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$31.84M	USD	2 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$14.20M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.24M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$4.35M	USD	1 Quarter
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$8.43M	USD	2 Qtrs
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$8.72M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$491.36M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$154.65M	USD	1 Quarter
Total expenses	`CostsAndExpenses`	$308.93M	USD	2 Qtrs
Total expenses	`CostsAndExpenses`	$254.31M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$15.38M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$41.59M	USD	2 Qtrs
Income from operations	`OperatingIncomeLoss`	$20.99M	USD	1 Quarter
Income from operations	`OperatingIncomeLoss`	$42.77M	USD	2 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.51M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.13M	USD	1 Quarter
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.94M	USD	2 Qtrs
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.81M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.85M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.85M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.93M	USD	2 Qtrs
Interest expense	`InterestExpense`	$3.38M	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$912.00K	USD	2 Qtrs
Interest income	`InvestmentIncomeInterest`	$421.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$563.00K	USD	1 Quarter
Interest income	`InvestmentIncomeInterest`	$467.00K	USD	2 Qtrs
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$83.77M	USD	2 Qtrs
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-10.83M	USD	2 Qtrs
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$-1.87M	USD	1 Quarter
Unrealized (loss) gain on investments	`UnrealizedGainLossOnInvestments`	$83.77M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-14.58M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$3.65M	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-15.88M	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$3.03M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$63.46M	USD	1 Quarter
Total other income (expense), net	`NonoperatingIncomeExpense`	$-6.70M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$62.91M	USD	2 Qtrs
Total other income (expense), net	`NonoperatingIncomeExpense`	$1.25M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$34.90M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$16.63M	USD	1 Quarter
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$105.68M	USD	2 Qtrs
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$84.45M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$31.70M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$24.92M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$6.04M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$12.23M	USD	2 Qtrs
Net income	`ProfitLoss`	$22.66M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.59M	USD	1 Quarter
Net income	`ProfitLoss`	$59.53M	USD	1 Quarter
Net income	`ProfitLoss`	$73.99M	USD	2 Qtrs
Net (loss) income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$48.18M	USD	2 Qtrs
Net (loss) income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-3.00M	USD	2 Qtrs
Net (loss) income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-808.00K	USD	1 Quarter
Net (loss) income attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$46.87M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$11.40M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.81M	USD	2 Qtrs
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$12.66M	USD	1 Quarter
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$25.66M	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.60	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.57	USD	2 Qtrs
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.25	USD	1 Quarter
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$0.29	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.28	USD	1 Quarter
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.58	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.56	USD	2 Qtrs
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.25	USD	1 Quarter

Cash Flow Statement 131 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$22.66M	USD	2 Qtrs
Net income	`ProfitLoss`	$10.59M	USD	1 Quarter
Net income	`ProfitLoss`	$59.53M	USD	1 Quarter
Net income	`ProfitLoss`	$73.99M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.72M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$8.43M	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$741.00K	USD	2 Qtrs
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$474.00K	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$2.90M	USD	2 Qtrs
Share-based compensation	`ShareBasedCompensation`	$6.97M	USD	2 Qtrs
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$2.27M	USD	1 Quarter
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	$2.27M	USD	2 Qtrs
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	-	USD	2 Qtrs
Gain on sale of equity securities	`EquitySecuritiesFvNiRealizedGainLoss`	-	USD	1 Quarter
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$83.77M	USD	2 Qtrs
Unrealized loss (gain) from investment in equity securities	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-13.66M	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$1.51M	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.13M	USD	1 Quarter
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$2.94M	USD	2 Qtrs
(Income) loss from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-3.81M	USD	2 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	$15.72M	USD	2 Qtrs
Impairment of beneficial interest	`AssetImpairmentCharges`	-	USD	2 Qtrs
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$2.83M	USD	2 Qtrs
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$-1.20M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$10.28M	USD	2 Qtrs
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$2.71M	USD	2 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	$189.00K	USD	2 Qtrs
Other	`ProceedsFromOtherOperatingActivities`	-	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$9.97M	USD	2 Qtrs
Receivables, net	`IncreaseDecreaseInAccountsReceivable`	$56.20M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$19.51M	USD	2 Qtrs
Receivables, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$12.15M	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$266.00K	USD	2 Qtrs
Other receivables	`IncreaseDecreaseInOtherReceivables`	$3.58M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-4.11M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-4.61M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$2.29M	USD	2 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$1.65M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$426.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.79M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$14.18M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$16.98M	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-550.00K	USD	2 Qtrs
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-4.46M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$55.11M	USD	2 Qtrs
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$8.98M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-13.29M	USD	2 Qtrs
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-2.01M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-2.25M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.70M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$370.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$33.06M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$31.29M	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$858.00K	USD	2 Qtrs
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$117.00K	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$4.03M	USD	2 Qtrs
Proceeds from repayment of loans receivable related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$31.00K	USD	2 Qtrs
Prepayment for investment purchase	`PrepaymentForInvestmentPurchase`	$4.45M	USD	2 Qtrs
Prepayment for investment purchase	`PrepaymentForInvestmentPurchase`	-	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.75M	USD	2 Qtrs
Purchase of marketable securities	`PaymentsToAcquireMarketableSecurities`	$670.00K	USD	2 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	$1.66M	USD	2 Qtrs
Purchase of investment equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$18.84M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$7.36M	USD	2 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	$3.32M	USD	2 Qtrs
Cash received from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$6.48M	USD	2 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.11M	USD	2 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$400.00K	USD	2 Qtrs
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	2 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	2 Qtrs
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$1.69M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.80M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-12.23M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$12.56M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$21.11M	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$238.21M	USD	2 Qtrs
Repayment of long-term debt	`RepaymentsOfLongTermDebt`	$200.00K	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$142.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$27.00K	USD	1 Quarter
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$283.00K	USD	2 Qtrs
Payment of finance lease obligations	`FinanceLeasePrincipalPayments`	$54.00K	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$1.74M	USD	2 Qtrs
Proceeds from the exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$4.82M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$9.48M	USD	2 Qtrs
Repurchase of shares	`PaymentsForRepurchaseOfCommonStock`	$2.98M	USD	2 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromSaleOfNoncontrollingInterest`	$38.00K	USD	2 Qtrs
Proceeds from sale of non-controlling interest	`ProceedsFromSaleOfNoncontrollingInterest`	$38.00K	USD	2 Qtrs
Purchase of non-controlling interest	`PaymentsToAcquireNonControllingInterest`	$199.00K	USD	2 Qtrs
Purchase of non-controlling interest	`PaymentsToAcquireNonControllingInterest`	$75.00K	USD	2 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfDebt`	$1.24M	USD	2 Qtrs
Borrowings on loans	`ProceedsFromIssuanceOfDebt`	$180.00M	USD	2 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	-	USD	2 Qtrs
Proceeds from sale of shares	`ProceedsFromIssuanceOfCommonStock`	$40.13M	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	2 Qtrs
Payment of debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$727.00K	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-19.70M	USD	2 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-38.17M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.13M	USD	2 Qtrs
Net increase (decrease) in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-16.68M	USD	2 Qtrs
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$23.32M	USD	2 Qtrs
Cash paid for income taxes	`IncomeTaxesPaid`	$22.31M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.51M	USD	2 Qtrs
Cash paid for interest	`InterestPaidNet`	$2.23M	USD	2 Qtrs
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$50.00K	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	-	USD	2 Qtrs
Fixed asset obtained in exchange for finance lease liabilities	`RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability`	$398.00K	USD	2 Qtrs
Common stock issued in business combination	`StockIssued1`	$1.00M	USD	2 Qtrs
Common stock issued in business combination	`StockIssued1`	-	USD	2 Qtrs
Cancellation of restricted stock awards	`CancellationOfRestrictedStockAwards`	$144.00K	USD	2 Qtrs
Cancellation of restricted stock awards	`CancellationOfRestrictedStockAwards`	-	USD	2 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	2 Qtrs
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	$16.27M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$234.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$234.22M	USD	Point-in-time
Cash, cash equivalents, restricted cash total	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$177.29M	USD	Point-in-time

Stockholders Equity 49 line items

Line Item	Tag	Value	Unit	Period
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$40.00M	USD	Point-in-time
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$40.00M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Equity, beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$13.70M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$15.20M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.74M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$12.67M	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$200.00K	USD	1 Quarter
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$36.00K	USD	1 Quarter
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$37.00K	USD	1 Quarter
Sale of shares by non-controlling interest	`StockIssuedDuringPeriodValueNoncontrollingInterest`	$40.13M	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-253.00K	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$165.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$561.00K	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$1.57M	USD	1 Quarter
Shares issued for exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$4.26M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$2.45M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	1 Quarter
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$342.00K	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.56M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.06M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$1.35M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.92M	USD	1 Quarter
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$144.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$189.00K	USD	1 Quarter
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$457.00K	USD	1 Quarter
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.77M	USD	1 Quarter
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$371.00K	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.37M	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.16M	USD	1 Quarter
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.18M	USD	1 Quarter
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$349.69M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$485.85M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$479.52M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$404.58M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Equity, ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.